P2K-19140-90470
3 vaccinations
4 coded responses
36 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 198 / DE
- Registered
- 2021-03-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-07
Registered in v-safe
-
2021-03-07
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-07
- 2021-03-08
- 2021-03-09
-
2021-03-10
Survey response — days 1–6 daily, dose 1MedDRA: Facial discomfort, Sinus disorder — Feeling: GoodFree text: Sinus/facial tendernessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-21
- 2021-03-28
- 2021-04-04
- 2021-04-11
- 2021-04-18
- 2021-06-06
-
2021-09-05
Survey response — 6 months, dose 1MedDRA: Postmenopausal haemorrhage, Uterine dilation and curettage — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Post menapausal bleeding · Healthcare visit (other): Ultrasound, d&cMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-05
Report sent to call center — 6 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-09
- 2021-09-13
-
2021-09-15
Call successfulParticipant prefers to complete VAERS report online
-
2021-10-24
Dose 2 — Pfizer-BioNTech
- 2021-10-31
- 2021-11-07
- 2021-11-14
- 2021-11-21
- 2021-11-28
- 2021-12-05
- 2022-01-23
- 2022-04-24
-
2022-05-02
Dose 3 — Pfizer-BioNTech
- 2022-05-05
-
2022-05-06
Survey response — days 1–6 daily, dose 3MedDRA: Pyrexia — Feeling: GoodFree text: I received the shot on 5/2/22. That day and the following I had a feverMedDRA releases: 2024-11 · check-in free text available
-
2022-05-07
Survey response — days 1–6 daily, dose 3MedDRA: Laryngitis — Feeling: FairFree text: LaryngitisMedDRA releases: 2024-11 · check-in free text available
- 2022-05-08
- 2022-05-09
- 2022-05-16
- 2022-05-23
- 2022-05-30
- 2022-06-06
- 2022-06-13
- 2022-08-01
- 2022-10-31
- 2023-05-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-07 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-24 | Pfizer-BioNTech | No |
| 3 | 2022-05-02 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-05 | Successful 2021-09-15 |
Participant prefers to complete VAERS report online |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Sinus/facial tenderness
Release 9 — 6 months, dose 1
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): I received the shot on 5/2/22. That day and the following I had a fever
Systemic reaction (other): Laryngitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Uterine dilation and curettage | ✓ | · | ✓ |
| SD | Postmenopausal haemorrhage | ✓ | · | ✓ |
| SRO | Facial discomfort | ✓ | ✓ | ✓ |
| SRO | Laryngitis | · | · | ✓ |
| SRO | Pyrexia | · | · | ✓ |
| SRO | Sinus disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release